Sign In
Buy ISRG
$407.29
+4.99 (+1.24%)
At Close: Jun 03, 2026
Intuitive Surgical, Inc. (ISRG) Recently Broke Out Above the 20-Day Moving Average
10:35am, Thursday, 20'th Nov 2025
After reaching an important support level, Intuitive Surgical, Inc. (ISRG) could be a good stock pick from a technical perspective. ISRG surpassed resistance at the 20-day moving average, suggesting a
17 Capital Partners LLC Boosts Holdings in Intuitive Surgical, Inc. $ISRG
04:03am, Thursday, 20'th Nov 2025
17 Capital Partners LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 7.9% during the undefined quarter, according to the company in its most recent disclosure with the
Where Will Intuitive Surgical Stock Be in 10 Years?
03:57am, Thursday, 20'th Nov 2025
Intuitive Surgical is selling an increasing number of da Vinci surgical robots. The number of procedures performed with a da Vinci robot is rising rapidly.
Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine?
09:06am, Wednesday, 19'th Nov 2025
Intuitive Surgical's Ion platform represents robust growth potential with strong procedure growth. Clinical trial data demonstrate superiority in diagnostic yield.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
10:02am, Tuesday, 18'th Nov 2025
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
PGIM Jennison Health Sciences Fund Q3 2025 Contributors And Detractors
02:31pm, Sunday, 16'th Nov 2025
The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Stock selection within biotechnology and health care providers & services, along with
Robotic Surgery Will Explode: Buy This Healthcare Stock Before Its 50% Run.
04:50am, Sunday, 16'th Nov 2025
Intuitive Surgical is a pioneer in the field of surgical robotics. The company's da Vinci system is a leading technology platform in its segment.
Intuitive Surgical (NASDAQ:ISRG) Trading Down 2.8% After Insider Selling
02:40am, Saturday, 15'th Nov 2025
Intuitive Surgical, Inc. (NASDAQ: ISRG - Get Free Report)'s share price fell 2.8% during trading on Friday after an insider sold shares in the company. The company traded as low as $548.92 and last tr
9 Robotics Stocks to Buy Before the Automation Wave Peaks
07:00pm, Friday, 14'th Nov 2025
Aging populations and wage inflation are making automation economically compelling across warehouses, factories, hospitals, and service industries. The robotics market encompasses a range of industrie
Intuitive Surgical Stock Is Up 31% Since October Lows After Powerful Earnings Turnaround
10:29am, Friday, 14'th Nov 2025
As the overall market trend weakens, one area that remains intact is medical stocks — namely Intuitive Surgical.
Baron Fifth Avenue Growth Fund Q3 2025 Performance Update
10:00am, Friday, 14'th Nov 2025
Baron Fifth Avenue Growth Fund gained 5.7% during the third quarter, lagging the 10.5% gain for the Russell 1000 Growth Index and the 8.1% gain for the S&P 500 Index, the Fund's benchmarks. NVIDIA rep
Is It Time to Dump Your Shares of Intuitive Surgical?
08:20am, Friday, 14'th Nov 2025
Intuitive Surgical makes da Vinci surgical robots used around the globe. The company has seen tremendous growth and is still growing quickly.
Is Force Feedback the Next Big Catalyst for ISRG's da Vinci Sales?
09:56am, Thursday, 13'th Nov 2025
Intuitive Surgical's new force-feedback upgrades for da Vinci 5 could spark its next adoption wave as early clinical evidence strengthens.
2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon
05:04am, Thursday, 13'th Nov 2025
These companies are leaders in their respective industries and are both very profitable. Intuitive Surgical has been the dominant presence in the surgical robotics market for decades.
The Motley Fool Analysts Andy Cross, Emily Flippen, and Jason Moser on How Tariffs Are Impacting Intuitive Surgical's Profits Right Now
09:00pm, Wednesday, 12'th Nov 2025
Intuitive Surgical reduced its projected tariff impact on gross margins by 30 basis points this quarter. The medical device leader's ability to navigate tariff uncertainty while raising guidance acros
